In October 2020, researchers discovered that the SARS-CoV-2 nonstructural protein 5 (NSP5) suppresses innate immunity. This has key implications for Covid-19 drug development that have yet to be fully explored.
Major Protease Of SARS-CoV-2 Acts To Suppress Innate Immunity
